Skip to main content
Article
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.
JAMA (2018)
  • Peter Pickkers, Radboud University Nijmegen
  • Ravindra L. Mehta, University of California, San Diego
  • Patrick T. Murray, University College Dublin
  • Michael Joannidis, Innsbruck Medical University
  • Bruce A. Molitoris, Indiana University – Purdue University Indianapolis
  • John A. Kellum, University of Pittsburgh
  • Mirjam Bachler, Innsbruck Medical University
  • Eric A. J. Hoste, Ghent University
  • Eric A. J. Hoste, Research Foundation - Flanders
  • Oscar Hoiting, Intensive Care, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands
  • Kenneth Krell, Internal Medicine, Eastern Idaho Regional Medical Center, Idaho Falls
  • Marlies Ostermann, King's College London
  • Wim Rozendaal, Bosch
  • Miia Valkonen, Helsinki University Central Hospital
  • David Brealey, National Institute for Health Research
  • David Brealey, University College Hospital
  • Albertus Beishuizen, Medisch Spectrum Twente
  • Ferhat Meziani, University of Strasbourg
  • Raghavan Murugan, University of Pittsburgh
  • Hilde de Geus, Erasmus University Rotterdam
  • Didier Payen, French Institute of Health and Medical Research
  • Erik van den Berg, Clinical Department, AM-Pharma BV, Bunnik, the Netherlands
  • Jacques Arend, Clinical Department, AM-Pharma BV, Bunnik, the Netherlands
Publication Date
November 20, 2018
DOI
10.1001/JAMA.2018.14283
Citation Information
Peter Pickkers, Ravindra L. Mehta, Patrick T. Murray, Michael Joannidis, et al.. "Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial." JAMA Vol. 320 Iss. 19 (2018) p. 1998 - 2009
Available at: http://works.bepress.com/kenneth-krell/5/